Müügiloaga pakend |
1201712
|
ACLASTA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,05mg 1ml 100ml 1TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
22.03.2024 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1265666
|
ACLASTA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,05mg 1ml 100ml 5TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1362439
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 2TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1362440
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1279997
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 2TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1280023
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1280001
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 4TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1280012
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 6TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1362462
|
ADROVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1300026
|
ALENDRONIC ACID ACCORD 70MG |
M05BA04 |
alendroonhape |
tablett |
70mg 4TK |
Accord Healthcare B.V. |
R |
Jah |
9.24 |
|
05.09.2023 |
|
|
|
Jah |
Müügiloaga pakend |
1441213
|
ALENDRONIC ACID ACCORD 70MG |
M05BA04 |
alendroonhape |
tablett |
70mg 12TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1696226
|
ALENDRONIC ACID/ COLECALCIFEROL SANDOZ |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
30.08.2019 |
|
|
|
Jah |
Müügiloaga pakend |
1696192
|
ALENDRONIC ACID/ COLECALCIFEROL SANDOZ |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 2TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1696215
|
ALENDRONIC ACID/ COLECALCIFEROL SANDOZ |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 6TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1696204
|
ALENDRONIC ACID/ COLECALCIFEROL SANDOZ |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Sandoz Pharmaceuticals d.d. |
R |
|
|
|
11.09.2020 |
|
|
|
Jah |
Müügiloaga pakend |
1742037
|
ALENDRONIC ACID/COLECALCIFEROL MYLAN |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 4TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1742060
|
ALENDRONIC ACID/COLECALCIFEROL MYLAN |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1742048
|
ALENDRONIC ACID/COLECALCIFEROL MYLAN |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 12TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1742059
|
ALENDRONIC ACID/COLECALCIFEROL MYLAN |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1695056
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 2TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1695034
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 12TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1695023
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 4TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1695078
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1695012
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 2TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1695067
|
ALENDRONIC ACID/COLECALCIFEROL ZENTIVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Zentiva k.s. |
R |
Jah |
7.28 |
|
18.11.2022 |
|
|
|
Jah |
Müügiloata ravim |
1603998
|
ALENDRONIC ACID/COLECALCIFEROL TEVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 28TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1603943
|
ALENDRONIC ACID/COLECALCIFEROL TEVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1603987
|
ALENDRONIC ACID/COLECALCIFEROL TEVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 24TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1603965
|
ALENDRONIC ACID/COLECALCIFEROL TEVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1603976
|
ALENDRONIC ACID/COLECALCIFEROL TEVA |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 16TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1823284
|
ALENDRONSÄURE STADA |
M05BA04 |
alendroonhape |
tablett |
70mg 12TK |
Stada Arzneimittel AG |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1245350
|
ALENOTOP |
M05BA04 |
alendroonhape |
tablett |
70mg 12TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1245361
|
ALENOTOP |
M05BA04 |
alendroonhape |
tablett |
70mg 40TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1245349
|
ALENOTOP |
M05BA04 |
alendroonhape |
tablett |
70mg 8TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1245327
|
ALENOTOP |
M05BA04 |
alendroonhape |
tablett |
70mg 2TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1245338
|
ALENOTOP |
M05BA04 |
alendroonhape |
tablett |
70mg 4TK |
Teva Pharma B.V. |
R |
|
|
|
07.06.2019 |
|
|
|
|
Müügiloata ravim |
1854075
|
AXIDRONAT |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
3mg 1ml 5ml 1TK |
AxioNovo GmbH |
R |
|
|
müügiloata pakend |
|
|
|
|
|
Müügiloata ravim |
1901517
|
AXIDRONAT |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
3mg 1ml 10ml 1TK |
AxioNovo GmbH |
R |
|
|
müügiloata pakend |
|
|
|
|
|
Müügiloata ravim |
1400858
|
BAXOGAR |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Zentiva k.s. |
R |
|
|
|
20.06.2017 |
|
|
|
|
Müügiloata ravim |
1400869
|
BAXOGAR |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1647604
|
BINOSTO |
M05BA04 |
alendroonhape |
kihisev tablett |
70mg 12TK |
EffRx Pharma GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1647615
|
BINOSTO |
M05BA04 |
alendroonhape |
kihisev tablett |
70mg 24TK |
EffRx Pharma GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1860027
|
BIODRONATE-30 |
M05BA03 |
pamidroonhape |
infusioonilahuse pulber |
30mg 1TK |
United Biotech Ltd |
R |
|
|
lahusti 10 ml |
|
|
|
|
|
Müügiloaga pakend |
1173158
|
BONDRONAT |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
1mg 1ml 6ml 5TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1173147
|
BONDRONAT |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
1mg 1ml 6ml 1TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
08.01.2013 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1207987
|
BONDRONAT |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
1mg 1ml 2ml 1TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1173169
|
BONDRONAT |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
1mg 1ml 6ml 10TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1173170
|
BONDRONAT |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1173181
|
BONDRONAT |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
31.05.2007 |
|
|
|
Jah |
Müügiloaga pakend |
1393275
|
BONEFURBIT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Orivas UAB |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1393286
|
BONEFURBIT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Orivas UAB |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1364699
|
BONVIVA |
M05BA06 |
ibandroonhape |
süstelahus |
1mg 1ml 3ml 4TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1364688
|
BONVIVA |
M05BA06 |
ibandroonhape |
süstelahus |
1mg 1ml 3ml 1TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1213209
|
BONVIVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
06.09.2021 |
|
|
|
Jah |
Müügiloaga pakend |
1213210
|
BONVIVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Atnahs Pharma Netherlands B.V. |
R |
|
|
|
27.11.2013 |
|
|
|
Jah |
Müügiloaga pakend |
1765683
|
CRYSVITA |
M05BX05 |
burosumab |
süstelahus |
20mg 1ml 1ml 1TK |
Kyowa Kirin Holdings B.V. |
R |
|
|
|
01.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1765694
|
CRYSVITA |
M05BX05 |
burosumab |
süstelahus |
30mg 1ml 1ml 1TK |
Kyowa Kirin Holdings B.V. |
R |
|
|
|
01.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1765672
|
CRYSVITA |
M05BX05 |
burosumab |
süstelahus |
10mg 1ml 1ml 1TK |
Kyowa Kirin Holdings B.V. |
R |
|
|
|
01.03.2024 |
|
|
|
Jah |
Müügiloata ravim |
1373150
|
ETANORDEN |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1373161
|
ETANORDEN |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1808546
|
EVENITY |
M05BX06 |
romosozumab |
süstelahus süstlis |
90mg 1ml 1.17ml 2TK |
UCB Pharma |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1808535
|
EVENITY |
M05BX06 |
romosozumab |
süstelahus pen-süstlis |
90mg 1ml 1.17ml 6TK |
UCB Pharma |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1808557
|
EVENITY |
M05BX06 |
romosozumab |
süstelahus süstlis |
90mg 1ml 1.17ml 6TK |
UCB Pharma |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1808524
|
EVENITY |
M05BX06 |
romosozumab |
süstelahus pen-süstlis |
90mg 1ml 1.17ml 2TK |
UCB Pharma |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1339130
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 2TK |
Organon N.V. |
R |
|
|
|
01.03.2011 |
|
|
|
Jah |
Müügiloaga pakend |
1213377
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1213366
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 6TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1213355
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 4TK |
Organon N.V. |
R |
|
|
|
12.12.2008 |
|
|
|
Jah |
Müügiloaga pakend |
1339152
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1213344
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 2TK |
Organon N.V. |
R |
|
|
|
11.01.2008 |
|
|
|
Jah |
Müügiloaga pakend |
1339141
|
FOSAVANCE |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Organon N.V. |
R |
Jah |
7.28 |
|
20.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1514360
|
IASIBON |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514214
|
IASIBON |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 5TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514337
|
IASIBON |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 6TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514359
|
IASIBON |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514168
|
IASIBON |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
1mg 1ml 1ml 1TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514348
|
IASIBON |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 9TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514225
|
IASIBON |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 10TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514180
|
IASIBON |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
2mg 2ml 2ml 1TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514281
|
IASIBON |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 3TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1514191
|
IASIBON |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 1TK |
Pharmathen S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1603202
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
2mg 2ml 2ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1681073
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
süstelahus süstlis |
1mg 1ml 3ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
06.07.2023 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1603224
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 5TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1603213
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
23.03.2023 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1603235
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 10TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1681084
|
IBANDRONIC ACID ACCORD |
M05BA06 |
ibandroonhape |
süstelahus süstlis |
1mg 1ml 3ml 4TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloata ravim |
1431571
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 28TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431559
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 20TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431537
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 10TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431548
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 14TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431560
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 21TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431526
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 7TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431582
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 30TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431504
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431515
|
IBANDRONIC ACID ACTAVIS 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431324
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 3TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431346
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 10TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431368
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 20TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431425
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 56TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431414
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 50TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431436
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 60TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431458
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 90TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431335
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 7TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431391
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 30TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431469
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 100TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431313
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 1TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431470
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 126TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431492
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 210TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431447
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431357
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 14TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431379
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 21TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431380
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431481
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 168TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1431403
|
IBANDRONIC ACID ACTAVIS 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 42TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1901999
|
IBANDRONIC ACID AUROBINDO |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
APL Swift Services Ltd |
R |
|
|
müügiloata pakend |
|
|
|
|
|
Müügiloata ravim |
1393231
|
IBANDRONIC ACID LICONSA 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1393242
|
IBANDRONIC ACID LICONSA 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1396201
|
IBANDRONIC ACID PORTFARMA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Portfarma ehf |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1396199
|
IBANDRONIC ACID PORTFARMA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Portfarma ehf |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1602009
|
IBANDRONIC ACID RATIOPHARM |
M05BA06 |
ibandroonhape |
süstelahus süstlis |
3mg 3ml 3ml 1TK |
Ratiopharm GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1601985
|
IBANDRONIC ACID RATIOPHARM |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 1TK |
Ratiopharm GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1601996
|
IBANDRONIC ACID RATIOPHARM |
M05BA06 |
ibandroonhape |
infusioonilahuse kontsentraat |
6mg 6ml 6ml 5TK |
Ratiopharm GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1579675
|
IBANDRONIC ACID SANDOZ |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Sandoz GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1579631
|
IBANDRONIC ACID SANDOZ |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 3TK |
Sandoz GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1579664
|
IBANDRONIC ACID SANDOZ |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Sandoz GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1579653
|
IBANDRONIC ACID SANDOZ |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 9TK |
Sandoz GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1579642
|
IBANDRONIC ACID SANDOZ |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 6TK |
Sandoz GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1431863
|
IBANDRONIC ACID SYNTHON 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 14TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431852
|
IBANDRONIC ACID SYNTHON 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 10TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431885
|
IBANDRONIC ACID SYNTHON 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431874
|
IBANDRONIC ACID SYNTHON 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431841
|
IBANDRONIC ACID SYNTHON 150MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 7TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431717
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 21TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431830
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 210TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431751
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 50TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431773
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 60TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431672
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 7TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431694
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 14TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431762
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 56TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431807
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 100TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431740
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 42TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431683
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 10TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431728
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431818
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 126TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431829
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 168TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431739
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 30TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431706
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 20TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431784
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1431795
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 90TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1488214
|
IBANDRONIC ACID SYNTHON 50MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 1TK |
Synthon B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1498956
|
IBANDRONIC ACID TEVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1498978
|
IBANDRONIC ACID TEVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Teva B.V. |
R |
Jah |
|
|
09.01.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1498989
|
IBANDRONIC ACID TEVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Teva B.V. |
R |
Jah |
|
|
15.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1498967
|
IBANDRONIC ACID TEVA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1703360
|
INDUCTOS |
M05BC01 |
alfadibotermiin |
implantatsioonimaatriksi pulber, lahusti ja maatriks |
1,5mg 1ml 2.8ml 1TK |
Medtronic Biopharma B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1212376
|
INDUCTOS |
M05BC01 |
alfadibotermiin |
implantatsioonimaatriksi pulber, lahusti ja maatriks |
1,5mg 1ml 8ml 1TK |
Medtronic Biopharma B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1393309
|
KEFORT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1393297
|
KEFORT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1341313
|
LENDRATE |
M05BA04 |
alendroonhape |
tablett |
70mg 12TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1341302
|
LENDRATE |
M05BA04 |
alendroonhape |
tablett |
70mg 4TK |
Actavis Group Ptc ehf. |
R |
|
|
|
30.11.2011 |
|
|
|
|
Müügiloata ravim |
1341290
|
LENDRATE |
M05BA04 |
alendroonhape |
tablett |
70mg 2TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1393264
|
LICOBONDRAT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 3TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1393253
|
LICOBONDRAT 150 MG |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
150mg 1TK |
Laboratorios Liconsa S.A. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1500950
|
MELENOR |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Medochemie Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1500949
|
MELENOR |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Medochemie Limited |
R |
|
|
|
23.08.2012 |
|
|
|
Jah |
Müügiloaga pakend |
1298268
|
NORIFAZ |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Adamed Pharma S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1298246
|
NORIFAZ |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 2TK |
Adamed Pharma S.A. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1298257
|
NORIFAZ |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Adamed Pharma S.A. |
R |
|
|
|
29.03.2023 |
|
|
|
Jah |
Müügiloata ravim |
1398742
|
OPGENRA |
M05BC02 |
alfaeptotermiin |
implantatsioonisuspensiooni pulber |
3,3mg 1TK |
Olympus Biotech International Limited |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1484423
|
OPGENRA |
M05BC02 |
alfaeptotermiin |
implantatsioonisuspensiooni pulber |
3,3mg 2TK |
Olympus Biotech International Limited |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1202577
|
OSIGRAFT |
M05BC02 |
alfaeptotermiin |
implantatsioonisuspensiooni pulber |
3,3mg 1TK |
Olympus Biotech International Limited |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1197705
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 56TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1197716
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 84TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1197671
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 7TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1197727
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 100TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1197682
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 14TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1197693
|
OSSEOR |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 28TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1373105
|
OSSICA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 84TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1373093
|
OSSICA |
M05BA06 |
ibandroonhape |
õhukese polümeerikattega tablett |
50mg 28TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1859272
|
PAMIDRONAT DINATRIUM PFIZER |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
3mg 1ml 10ml 1TK |
Pfizer Service Company BVBA |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1137170
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 1ml 1TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1150377
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 4ml 4TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1137181
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 2ml 1TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
06.10.2020 |
|
|
Jah |
|
Müügiloata ravim |
1150355
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 1ml 4TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1150366
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 2ml 4TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1137192
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 4ml 1TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
15.12.2020 |
|
|
Jah |
|
Müügiloata ravim |
1137204
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 6ml 1TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
22.08.2017 |
|
|
Jah |
|
Müügiloata ravim |
1150388
|
PAMITOR 15 MG/ML |
M05BA03 |
pamidroonhape |
infusioonilahuse kontsentraat |
15mg 1ml 6ml 4TK |
CHIESI Pharmaceuticals GmbH |
R |
|
|
|
|
|
|
Jah |
|
Müügiloaga pakend |
1481857
|
PROLIA |
M05BX04 |
denosumab |
süstelahus süstlis |
60mg 1ml 1ml 1TK |
Amgen Europe B.V. |
R |
Jah |
|
|
22.03.2024 |
|
|
Jah |
Jah |
Müügiloata ravim |
1481868
|
PROLIA |
M05BX04 |
denosumab |
süstelahus |
60mg 1ml 1ml 1TK |
Amgen Europe B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1207831
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 56TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1207819
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 14TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1207886
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 100TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1186949
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 28TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1207842
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 84TK |
Les Laboratoires Servier |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1207808
|
PROTELOS |
M05BX03 |
strontsiumranelaat |
suukaudse suspensiooni graanulid |
2g 7TK |
Les Laboratoires Servier |
R |
|
|
|
18.02.2011 |
|
|
Jah |
|
Müügiloata ravim |
1301241
|
RIBIDRON |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Ratiopharm GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1301230
|
RIBIDRON |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 8TK |
Ratiopharm GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1301229
|
RIBIDRON |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Ratiopharm GmbH |
R |
|
|
|
12.12.2013 |
|
|
|
|
Müügiloaga pakend |
1310779
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 10TK |
Accord Healthcare B.V. |
H |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310768
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 8TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310735
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 1TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310803
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 16TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310825
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 50TK |
Accord Healthcare B.V. |
H |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310780
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Accord Healthcare B.V. |
R |
Jah |
30.24 |
|
21.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1310791
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 14TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310746
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 2TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1310757
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Accord Healthcare B.V. |
H |
Jah |
10.08 |
|
02.12.2020 |
|
|
|
Jah |
Müügiloaga pakend |
1310814
|
RISEDRONATE SODIUM ACCORD |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 30TK |
Accord Healthcare B.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1298325
|
RISEDRONATE SODIUM ACTAVIS |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 2TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1298336
|
RISEDRONATE SODIUM ACTAVIS |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Actavis Group Ptc ehf. |
R |
|
|
|
15.12.2015 |
|
|
|
|
Müügiloata ravim |
1298347
|
RISEDRONATE SODIUM ACTAVIS |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1285703
|
RISENDROS 35MG |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 12TK |
Zentiva k.s. |
R |
|
|
|
11.06.2010 |
|
|
|
Jah |
Müügiloaga pakend |
1285679
|
RISENDROS 35MG |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 2TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1285680
|
RISENDROS 35MG |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 4TK |
Zentiva k.s. |
R |
Jah |
10.08 |
|
22.12.2022 |
|
|
|
Jah |
Müügiloaga pakend |
1285691
|
RISENDROS 35MG |
M05BA07 |
risedroonhape |
õhukese polümeerikattega tablett |
35mg 8TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1240120
|
SEDRON |
M05BA04 |
alendroonhape |
õhukese polümeerikattega tablett |
70mg 4TK |
Gedeon Richter Plc. |
R |
|
|
|
19.03.2020 |
|
|
|
|
Müügiloata ravim |
1240119
|
SEDRON |
M05BA04 |
alendroonhape |
õhukese polümeerikattega tablett |
70mg 2TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1240131
|
SEDRON |
M05BA04 |
alendroonhape |
õhukese polümeerikattega tablett |
70mg 12TK |
Gedeon Richter Plc. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1835401
|
SEDRON |
M05BA04 |
alendroonhape |
õhukese polümeerikattega tablett |
70mg 4TK |
Ideal Trade Links UAB |
R |
Jah |
9.24 |
Poola pakend |
05.10.2022 |
|
|
|
Jah |
Müügiloata ravim |
1493973
|
STEOVESS |
M05BA04 |
alendroonhape |
kihisev tablett |
70mg 4TK |
EffRx Pharma GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1647569
|
STEOVESS |
M05BA04 |
alendroonhape |
kihisev tablett |
70mg 12TK |
EffRx Pharma GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1647570
|
STEOVESS |
M05BA04 |
alendroonhape |
kihisev tablett |
70mg 24TK |
EffRx Pharma GmbH |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1589867
|
ZENDRACTIN |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 1TK |
PharmaSwiss Ceska republika s.r.o. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1616127
|
ZENDRACTIN |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 10TK |
PharmaSwiss Ceska republika s.r.o. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1589878
|
ZENDRACTIN |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 4TK |
PharmaSwiss Ceska republika s.r.o. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1589889
|
ZENDRACTIN |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 5TK |
PharmaSwiss Ceska republika s.r.o. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1526701
|
ZOLACITOR |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Norameda UAB |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1526712
|
ZOLACITOR |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 4TK |
Norameda UAB |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1637984
|
ZOLEDRONIC ACID ACCORD |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 10TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1637962
|
ZOLEDRONIC ACID ACCORD |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 1TK |
Accord Healthcare S.L.U. |
R |
|
|
|
29.02.2024 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1637973
|
ZOLEDRONIC ACID ACCORD |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 4TK |
Accord Healthcare S.L.U. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloata ravim |
1567964
|
ZOLEDRONIC ACID ACTAVIS |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 10TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1567953
|
ZOLEDRONIC ACID ACTAVIS |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 4TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1567942
|
ZOLEDRONIC ACID ACTAVIS |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 1TK |
Actavis Group Ptc ehf. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloaga pakend |
1529850
|
ZOLEDRONIC ACID FRESENIUS KABI 4MG/5ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 4TK |
Fresenius Kabi Polska Sp. z o.o. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1529861
|
ZOLEDRONIC ACID FRESENIUS KABI 4MG/5ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 10TK |
Fresenius Kabi Polska Sp. z o.o. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1529849
|
ZOLEDRONIC ACID FRESENIUS KABI 4MG/5ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Fresenius Kabi Polska Sp. z o.o. |
R |
|
|
|
06.03.2024 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1831395
|
ZOLEDRONIC ACID HOSPIRA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Pfizer Europe MA EEIG |
R |
|
|
klaasviaal |
|
|
|
|
Jah |
Müügiloaga pakend |
1603246
|
ZOLEDRONIC ACID HOSPIRA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Pfizer Europe MA EEIG |
R |
|
|
plastviaal |
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1603268
|
ZOLEDRONIC ACID HOSPIRA |
M05BA08 |
zoledroonhape |
infusioonilahus |
5mg 100ml 100ml 1TK |
Pfizer Europe MA EEIG |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1603257
|
ZOLEDRONIC ACID HOSPIRA |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 1TK |
Pfizer Europe MA EEIG |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1592939
|
ZOLEDRONIC ACID MYLAN |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 1TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1592951
|
ZOLEDRONIC ACID MYLAN |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 10TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1592940
|
ZOLEDRONIC ACID MYLAN |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 4TK |
Mylan Pharmaceuticals Limited |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1722350
|
ZOLEDRONIC ACID NORAMEDA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 1TK |
Norameda UAB |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloata ravim |
1540101
|
ZOLEDRONIC ACID PFIZER |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Pfizer Europe MA EEIG |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1523539
|
ZOLEDRONIC ACID ZENTIVA 4 MG/ 5 ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1523551
|
ZOLEDRONIC ACID ZENTIVA 4 MG/ 5 ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 5TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1523540
|
ZOLEDRONIC ACID ZENTIVA 4 MG/ 5 ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 4TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloata ravim |
1523562
|
ZOLEDRONIC ACID ZENTIVA 4 MG/ 5 ML |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 10TK |
Zentiva k.s. |
R |
|
|
|
|
|
|
Jah |
|
Müügiloaga pakend |
1596124
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 4TK |
Teva B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1665817
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 1TK |
Teva B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1596113
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 1TK |
Teva B.V. |
R |
|
|
|
09.01.2020 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1665828
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 4TK |
Teva B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1596135
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 10TK |
Teva B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1665839
|
ZOLEDRONIC ACID TEVA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 10TK |
Teva B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloata ravim |
1644533
|
ZOLEDRONIC ACID TEVA GENERICS |
M05BA08 |
zoledroonhape |
infusioonilahus |
5mg 100ml 100ml 5TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1644544
|
ZOLEDRONIC ACID TEVA GENERICS |
M05BA08 |
zoledroonhape |
infusioonilahus |
5mg 100ml 100ml 10TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1644522
|
ZOLEDRONIC ACID TEVA GENERICS |
M05BA08 |
zoledroonhape |
infusioonilahus |
5mg 100ml 100ml 1TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1596539
|
ZOLEDRONIC ACID TEVA PHARMA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,05mg 1ml 100ml 10TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1633643
|
ZOLEDRONIC ACID TEVA PHARMA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,05mg 1ml 100ml 1TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1596528
|
ZOLEDRONIC ACID TEVA PHARMA |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,05mg 1ml 100ml 5TK |
Teva B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1590791
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 10TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1590814
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 4TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1590780
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 4TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1590779
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
0,8mg 1ml 5ml 1TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
31.08.2015 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1590803
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 1TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1590825
|
ZOLEDROONHAPE MEDAC |
M05BA08 |
zoledroonhape |
infusioonilahus |
0,04mg 1ml 100ml 10TK |
Medac Gesellschaft für klinische Spezialpräparate mbH |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1538647
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 5TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1210240
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 10TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1538625
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 1TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
28.08.2013 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1060298
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse pulber ja lahusti |
4mg 1TK |
Phoenix Labs Unlimited Company |
R |
|
|
lahusti 5 ml |
26.04.2012 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1060311
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse pulber ja lahusti |
4mg 10TK |
Phoenix Labs Unlimited Company |
R |
|
|
lahusti 5 ml |
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1210239
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 4TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1210228
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse kontsentraat |
4mg 5ml 5ml 1TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1538636
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahus |
4mg 100ml 100ml 4TK |
Phoenix Labs Unlimited Company |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1060300
|
ZOMETA |
M05BA08 |
zoledroonhape |
infusioonilahuse pulber ja lahusti |
4mg 4TK |
Phoenix Labs Unlimited Company |
R |
|
|
lahusti 5 ml |
|
|
|
Jah |
Jah |
Müügiloata ravim |
1196333
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 40TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1196322
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 12TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1196344
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 50TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1196287
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 2TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1196311
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 8TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1196300
|
TEVANATE 70 MG |
M05BA04 |
alendroonhape |
tablett |
70mg 4TK |
Teva Pharma B.V. |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1677269
|
TRIDEPOS |
M05BB05 |
alendroonhape +kaltsium +kolekaltsiferool |
õhukese polümeerikattega tablett + tablett |
70mg +0 +0/0 +500mg +800RÜ 4TK / 24TK |
Meda Pharma SIA |
R |
|
|
|
|
|
|
|
|
Müügiloata ravim |
1677281
|
TRIDEPOS |
M05BB05 |
alendroonhape +kaltsium +kolekaltsiferool |
õhukese polümeerikattega tablett + tablett |
70mg +0 +0/0 +500mg +800RÜ 12TK / 72TK |
Meda Pharma SIA |
R |
|
|
|
|
|
|
|
|
Müügiloaga pakend |
1447422
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447354
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 4TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447343
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 2TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447365
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 6TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447400
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 4TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447398
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +5600RÜ 2TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1447376
|
VANTAVO |
M05BB03 |
alendroonhape +kolekaltsiferool |
tablett |
70mg +2800RÜ 12TK |
Organon N.V. |
R |
|
|
|
|
|
|
|
Jah |
Müügiloaga pakend |
1861152
|
VOXZOGO |
M05BX07 |
vosoritiid |
süstelahuse pulber ja lahusti |
0,4mg 10TK |
BioMarin International Limited |
R |
|
|
|
12.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1861163
|
VOXZOGO |
M05BX07 |
vosoritiid |
süstelahuse pulber ja lahusti |
0,56mg 10TK |
BioMarin International Limited |
R |
|
|
|
12.03.2024 |
|
|
|
Jah |
Müügiloaga pakend |
1861174
|
VOXZOGO |
M05BX07 |
vosoritiid |
süstelahuse pulber ja lahusti |
1,2mg 10TK |
BioMarin International Limited |
R |
|
|
|
|
|
|
|
Jah |
Müügiloata ravim |
1890581
|
VOXZOGO |
M05BX07 |
vosoritiid |
süstelahuse pulber ja lahusti |
0,56mg 10TK |
BioMarin International Limited |
R |
|
|
müügiloata pakend |
|
|
|
|
|
Müügiloaga pakend |
1536982
|
XGEVA |
M05BX04 |
denosumab |
süstelahus |
70mg 1ml 1.7ml 1TK |
Amgen Europe B.V. |
R |
|
|
|
22.03.2024 |
|
|
Jah |
Jah |
Müügiloaga pakend |
1536993
|
XGEVA |
M05BX04 |
denosumab |
süstelahus |
70mg 1ml 1.7ml 4TK |
Amgen Europe B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |
Müügiloaga pakend |
1555354
|
XGEVA |
M05BX04 |
denosumab |
süstelahus |
70mg 1ml 1.7ml 3TK |
Amgen Europe B.V. |
R |
|
|
|
|
|
|
Jah |
Jah |